Does a clear PRA DNA test guarantee my dog will not go blind?
No. It rules out only the specific variants that test covers. Other retinal variants, including uncharacterised ones, would not be detected.
Quick answer
Does a clear PRA DNA test guarantee my dog will not go blind?
No. It rules out only the specific variants that test covers. Other retinal variants, including uncharacterised ones, would not be detected.
A negative DNA result only tells you your dog does not have the exact variant that test looks for.

Owners and breeders trying to work out which eye tests are appropriate for a Mastiff, and anyone who has been handed a DNA panel result and does not know what it rules out.
This guide is not medical advice. If your dog shows pain, sudden behavior change, or worsening symptoms, consult a licensed veterinarian.
Some links may be affiliate links. We may earn a commission at no extra cost to you. We only suggest products we believe are helpful for dog owners.
Progressive retinal atrophy is a group of inherited diseases, each caused by a different genetic variant, and rcd3 is one named form characterised in particular breeds. DNA tests detect one specific variant each, so a clear result rules out only that variant. Since retinal atrophy is documented in Mastiffs without every named form necessarily being the responsible one, choosing the right test and combining it with specialist eye examination is the whole point.
Progressive retinal atrophy as a category is listed among the Mastiff's documented health issues. Which specific variants are responsible in this breed is a question for breed health authorities rather than something a commercial panel answers by including a test. Carrier frequencies vary between breeds and between populations, and testing data accumulates over time.
This is entirely a genetic matter and has nothing to do with the Mastiff's size, coat or head shape. Progressive retinal atrophy appears explicitly among the breed's documented health problems, which places it alongside hip dysplasia and cardiac disease as something responsible breeding programmes address. Purebred populations concentrate genetic variants of every kind, which is why breed-specific testing regimes exist at all. Which named variant applies in a given breed is determined by research in that population, not by extrapolation from another.
Nothing environmental causes or prevents inherited retinal disease, and owners should be wary of products claiming otherwise. What human decisions control entirely is the flow of information: whether breeding stock is tested, whether the correct test was chosen, whether examinations are repeated as dogs age, and whether results are documented and passed on to puppy buyers. A well-run breed health scheme changes outcomes across generations, while an untested line simply passes uncertainty forward.
Talk to your vet before ordering DNA testing, to establish which variants are relevant, and afterwards to interpret what a result does and does not exclude. Book a specialist eye examination if your Mastiff has become hesitant in dim light, is bumping into things, or has pupils that appear permanently wide, regardless of any DNA result. Seek same-day care instead for a red, cloudy, squinting or painful eye, for an eye that looks enlarged, for a pupil that has suddenly changed, or for vision lost over hours rather than months, since sudden painful vision loss is an emergency and is not what inherited retinal atrophy looks like.
See all Mastiff health problems, which breeds are prone to progressive retinal atrophy pra rcd3, or the full Mastiff breed guide for temperament, exercise needs and ownership costs.
A DNA result comes back in a matter of weeks from a cheek swab or blood sample and is valid for life, since genetics do not change. Specialist eye examinations must be repeated, typically annually or at whatever interval your breed scheme sets, because retinal disease develops with age. If a dog tests affected, the interval between that result and any visible vision loss can be years, and using that time is the whole benefit of testing early.
Success is knowing precisely what you do and do not know. That means the right test was run, the result was recorded and passed on, eye examinations continue on schedule, and no false reassurance was taken from a panel that did not cover the relevant variant. For breeders, success is a programme that avoids carrier-to-carrier pairings without narrowing the gene pool unnecessarily. For pet owners, it is usually simply a well-informed decision at the point of buying a puppy.
The rcd3 form of progressive retinal atrophy is one named variant among many. It has been characterised in specific breeds, and a laboratory test for it looks for that exact change in that exact gene. That is what makes DNA testing powerful: a clear yes or no, from a cheek swab, often before a dog has any symptoms at all.
It is also what makes it narrow. If your Mastiff carries a different retinal variant, or a form that has not yet been characterised, an rcd3 test returns clear and your dog can still go blind. The test was not wrong; it answered a different question from the one you were asking.
Progressive retinal atrophy is documented among the Mastiff's health issues, but the presence of a condition in a breed does not automatically mean a specific named variant is the cause in that breed. Before ordering any DNA test, the question to ask a vet or a breed health coordinator is whether that particular variant has actually been identified in Mastiffs. Commercial panels will happily test for dozens of variants regardless of relevance.
This is why a specialist eye examination remains central. An ophthalmologist looking at the retina is assessing what is actually there, regardless of which gene is responsible. DNA testing tells you about a specific risk before it manifests; examination tells you about the dog in front of you. Breeding programmes typically use both, and neither substitutes for the other.
For most recessively inherited retinal variants, a DNA test returns one of three outcomes, and the practical meaning of each differs sharply.

If you think your Mastiff has progressive retinal atrophy (pra-rcd3), the plan is three steps: write down what you have seen and when it started, book a veterinary appointment rather than waiting for the next flare, and take video of the behaviour or symptom before you go — the thing you are worried about rarely happens in the consulting room. Screening in the parents covers hip dysplasia, elbow dysplasia, cancer.
What the vet visit should produce is a diagnosis and a written plan, not just reassurance: what is being ruled out, what the monitoring interval is, and which signs mean you come back sooner. Ask what the treatment costs across a year rather than per visit, because that is the number that decides whether you are managing this condition or reacting to it.
Between appointments, keep a short log — dates, what you saw, what changed. It is the single most useful thing an owner brings to a follow-up, and for progressive retinal atrophy (pra-rcd3) it is often what separates a clear pattern from a guess.
Ferdie bought a Mastiff puppy from a breeder who supplied a commercial DNA panel showing clear for progressive retinal atrophy. It ran to four pages and looked thorough, and Ferdie took it as settled. At eight, his dog Melisande began refusing the garden after dark. Within a year she was bumping into things in daylight, and an ophthalmologist confirmed retinal degeneration. Ferdie went back to the paperwork. The panel had tested for a set of named variants, none of which had been established as the relevant form in Mastiffs. It was a perfectly accurate result to a question that had never applied to his dog. What he wishes he had done differently was not to skip the panel but to ask two questions alongside it: which variants matter in this breed, and have the parents had specialist eye examinations. The second question, he now thinks, was the more useful of the two.
Key takeaway: A DNA panel answers only the questions it was built to ask. In a breed where retinal atrophy is documented but the responsible variants may not be the ones on a commercial list, repeated specialist eye examinations remain the check that cannot return a confidently irrelevant answer.
This is exactly the question to put to your vet or the breed's health coordinator before ordering a test. Named variants are characterised breed by breed, and a test that is highly informative in one breed can be irrelevant in another. Do not assume a panel is relevant simply because it includes a PRA test and your breed has documented PRA.
Not necessarily. The panel tested for the specific variants it includes. If your Mastiff has a different retinal variant, or one not yet identified, the panel cannot detect it. A clear panel result is genuinely useful information but it is not a guarantee of lifelong vision, and it should not replace eye examinations.
For a pet, carrier status has no health implications at all and is not a reason to change anything. For a breeding animal it matters, but removing every carrier from a numerically limited breed can narrow the gene pool and cause other problems. Discuss it with people who understand the breed's population rather than acting on a single result.
It assesses the retina as it actually is, whatever the genetics. Specialist examinations detect disease from causes no test covers, and can also identify unrelated conditions such as cataracts or eyelid problems that need attention. Breeding programmes normally require examinations at intervals rather than one test result for life.
Repeatedly rather than once, because retinal degeneration develops with age and a clear examination in a two-year-old says nothing about the same dog at six. Your breed health scheme will have a recommended interval. This is the same logic that applies to thyroid antibody testing, where status can change over time.
It means the disease is expected to develop, not that it has. Ask your vet to arrange a baseline specialist examination and a monitoring interval. The practical benefit is preparation: you can begin teaching directional cues and keep your household layout stable well before vision is lost, which is much easier than adapting in a hurry.
No. It rules out only the specific variants that test covers. Other retinal variants, including uncharacterised ones, would not be detected.
Whether that specific variant has actually been identified in Mastiffs. Commercial panels test many variants regardless of whether they are relevant to your breed.
One normal and one variant copy. For a recessive condition the dog will not develop the disease but can pass the variant on. It matters for breeding, not for a pet's health.
Examination assesses the actual retina whatever the genetics, catches conditions no panel covers, and must be repeated because degeneration develops with age.
Arrange a baseline specialist examination and a monitoring interval, and start preparing the household and directional training early rather than after sight is gone.
A one-page prep sheet for this condition: the signs, the questions to ask, what to get priced. Unlocks here.
You get: Vet visit prep sheet
No spam. One-click unsubscribe. See our privacy policy.
Preview page 1 before you decide.





